Search results
Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)
FOX 59 Indianapolis· 6 days agoSamuel Zhang as its Global Chief Business Officer (CBO). In this role, Dr. Zhang will be responsible...
Opinion: US needs immigrants, who will be powerful engine of economic growth
Gannett via AOL· 10 hours agoImmigration, by adding younger workers, can help cover the shortfall. Under likely economic...
Bottomline | The risk of rising debt for USD and beyond
MSN News· 12 hours agoWhen Elon Musk says anything, people take notice. And when he says that the dollar will be worth...
Ana Andjelic
Forbes· 6 hours agoBecause by "doing things differently, despite established wisdom, traditional practices, or consensus," Andjelic is rebuilding and revitalizing the ESPRIT brand and business. In just the past ...
New Cold War with a new axis of evil: Isolationists in the US, GOP must join the fight as dark...
New York Post· 7 days agoSpain, true of ancien régime France, true of the Ottoman Empire, true of the British Empire, this...
Proposed nursing shortage fix riles unions
Politico· 5 days agoCBO BILL PASSES HOUSE — The House passed legislation by voice vote Monday that would make it easier for the Congressional Budget Office to get data from federal agencies like ...
Nikki Neuburger
Forbes· 6 hours agoBecause for Neuburger, creating the "new" is both a set of objectives and a mandate for how she approaches marketing and driving growth across "new markets, new consumer segments and new product ...
David Ditch: Wasteful government spending adds up – and all of us pay the price
Winston-Salem Journal· 3 days agoThis should come as no surprise, since excessive deficit spending from Washington remains much too...
Insider Crombez Eric sells 142 of Ultragenyx Pharmaceutical Inc. [RARE] Stock – Knox Daily
Knox Daily· 5 days agoThen, Kassberg Thomas Richard sold 11,509 shares, generating $574,644 in total proceeds. Upon selling the shares at $49.93, the CBO & EVP now owns 252,823 shares. Before that ...
BIOSECURE bill targets more Chinese companies as biotechs and their customers adapt to defunding
Pharmaceutical Technology via Yahoo Finance· 6 days agoAlthough many US pharma companies contract with Chinese firms, the US Congressional Budget Office (...
